President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs.

Working in the same office as your spouse might be tricky for some people. But for one Hollis couple, they say going to work together is the reason that, at 70 years old, they still have no plans to ...

A French government working group recommended a sweeping plan to publicize study data and issue guidelines for reporting ...

Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...

By Andrew Silver SHANGHAI (Reuters) -German healthcare and materials group Merck KGaA has dropped a surcharge on life ...

SHANGHAI (Reuters) -Australia will "not compromise" on its policy to subsidise the cost of some medicines, the government ...

The Unified Patent Court (UPC) has quickly become an important forum for pharmaceutical and biotech patent disputes in Europe ...

Discover top income-generating picks inspired by Berkshire Hathaway. Learn how to achieve financial independence with yields ...

Michael Lämmerhofer from the Institute of Pharmaceutical Sciences, University of Tübingen, Germany, spoke to JFK Huber ...

Michael Lämmerhofer from the Institute of Pharmaceutical Sciences, University of Tübingen, Germany, spoke to JFK Huber ...

Trump spoke about a sweeping executive order he signed Monday that promised to lower prescription drug prices by between 59% ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...